If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
3mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is Baqsimi™ (glucagon) nasal powder indicated for?
Glucagon nasal powder is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.
US_cFAQ_NG035_INDICATION
en-US
Indication
Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1
Enclosed Prescribing Information
Reference
1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Date of Last Review: October 25, 2021
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays